NeOnc Technologies Holdings Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About NeOnc Technologies Holdings Inc.
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration (FDA).
/ 
Others were interested in
Frequently asked questions
To buy NeOnc Technologies Holdings Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for NeOnc Technologies Holdings Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for NeOnc Technologies Holdings Inc. is NTHI:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
NeOnc Technologies Holdings Inc. has its primary listing on NASDAQ. You can trade NeOnc Technologies Holdings Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, NeOnc Technologies Holdings Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include NeOnc Technologies Holdings Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like NeOnc Technologies Holdings Inc..